| Access Behavioral Associates Llc | |
|
42189 Ann Arbor Rd E Plymouth MI 48170-4370 | |
| (734) 453-5603 | |
| (734) 453-5619 |
| Full Name | Access Behavioral Associates Llc |
|---|---|
| Speciality | Social Worker |
| Location | 42189 Ann Arbor Rd E, Plymouth, Michigan |
| Authorized Official Name and Position | Karl Lawrence Senkowski (CLINICAL DIRECTOR) |
| Authorized Official Contact | 7344535603 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Access Behavioral Associates Llc 42189 Ann Arbor Rd E Plymouth MI 48170-4370 Ph: (734) 453-5603 | Access Behavioral Associates Llc 42189 Ann Arbor Rd E Plymouth MI 48170-4370 Ph: (734) 453-5603 |
| NPI Number | 1033771837 |
|---|---|
| Provider Enumeration Date | 07/01/2019 |
| Last Update Date | 07/01/2019 |
| Medicare PECOS PAC ID | 4486983871 |
|---|---|
| Medicare Enrollment ID | O20190910003109 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Women with dense breast tissue are at increased risk of breast cancer. Dense breast tissue, generally defined as having more fibroglandular than fatty tissue, can make it more difficult for radiologists to detect cancer on screening mammography.
There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA).
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033771837 | NPI | - | NPPES |
| Provider Name | Karl L Senkowski |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649361494 PECOS PAC ID: 1052389335 Enrollment ID: I20051212000624 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Women with dense breast tissue are at increased risk of breast cancer. Dense breast tissue, generally defined as having more fibroglandular than fatty tissue, can make it more difficult for radiologists to detect cancer on screening mammography.
There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA).
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
| Provider Name | Roberta L Martin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1972531689 PECOS PAC ID: 0244321925 Enrollment ID: I20070809000552 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Women with dense breast tissue are at increased risk of breast cancer. Dense breast tissue, generally defined as having more fibroglandular than fatty tissue, can make it more difficult for radiologists to detect cancer on screening mammography.
There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA).
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
| Provider Name | Mary H Bleyaert |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1942393558 PECOS PAC ID: 0345376893 Enrollment ID: I20100413000043 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Women with dense breast tissue are at increased risk of breast cancer. Dense breast tissue, generally defined as having more fibroglandular than fatty tissue, can make it more difficult for radiologists to detect cancer on screening mammography.
There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA).
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Women with dense breast tissue are at increased risk of breast cancer. Dense breast tissue, generally defined as having more fibroglandular than fatty tissue, can make it more difficult for radiologists to detect cancer on screening mammography.
There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA).
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
› Verified 4 days ago
Steven J Ceresnie Phd Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 199 N Main St, Plymouth, MI 48170 Phone: 734-453-9290 Fax: 734-453-9293 | |
Mkaye Counseling, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 N Evergreen St, Plymouth, MI 48170 Phone: 734-277-1810 | |
Metroehs Pediatric Therapy Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 44670 Ann Arbor Rd W Ste 130, Plymouth, MI 48170 Phone: 313-278-4601 | |
Mangin Psychological Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 42233 Ann Arbor Rd E, Plymouth, MI 48170 Phone: 734-386-0452 Fax: 734-419-9023 | |
Evergreen Hope Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 270 S Union St, Plymouth, MI 48170 Phone: 920-246-1465 | |
Unmasking The Fear Counseling Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9341 N Haggerty Rd, Plymouth, MI 48170 Phone: 313-570-0636 |